Abstract
Orvinols are potent analgesics that target opioid receptors. However, their analgesic mechanism remains unclear and no significant preference for subtype opioid receptor has been achieved. In order to find new orvinols that target the κ-receptor, comparative 3D–QSAR studies were performed on 26 orvinol analogs using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA). The best predictions for the κ-receptor were obtained with the CoMFA standard model (q 2=0.686, r 2=0.947) and CoMSIA model combined steric, electrostatic, hydrophobic, and hydrogen bond donor/acceptor fields (q 2=0.678, r 2=0.914). The models built were further validated by a test set made up of seven compounds, leading to predictive r 2 values of 0.672 for CoMFA and 0.593 for CoMSIA. The study could be helpful for designing and prepare new category κ-agonists from orvinols.
Similar content being viewed by others
References
Bentley KW, Hardy DG (1967) J Am Chem Soc 89:3281–3292
Bently KW, Hardy DG (1967) J Am Chem Soc 89:3267–3273
Eguchi M (2004) Med Res Rev 24:182–212
Husbands SM (2004) Expert Opin Ther Patents 14:1725–1741
Lewis JW, Husbands SM (2004) Curr Pharm Des 10:717–732
Traynor JR, Guo L, Coop A, Lewis JW, Woods JH (1999) J Pharmacol Exp Ther 291:1093–1099
Coop A, Norton CL, Berzetei-Gurske I, Burnside J, Toll L, Husbands SM, Lewis JW (2000) J Med Chem 43:1852–1857
Bermejo FM, Husbands SM, Lewis JW (1999) Hel Chim Acta 82:1721–1727
Grundt P, Martinez-Bermejo F, Lewis JW, Husbands SM (2003) J Med Chem 46:3174–3177
Husbands SM, Neilan CL, Broadbear J, Grundt P, Breeden S, Aceto MD, Woods JH, Lewis JW, Traynor JR (2005) Eur J Pharmacol 509:117–125
Husbands SM, Breeden SW, Grivas K, Lewis JW (1999) Bioorg Med Chem Lett 9:831–834
Grundt P, Jales AR, Traynor JR, Lewis JW, Husbands SM (2003) J Med Chem 46:1563–1566
Grundt P, Martinez-Bermejo F, Lewis JW, Husbands SM (2003) Hel Chim Acta 86:793–798
SYBYL, version 6.9 (2003) 1699 Hanley Road, St. Louis, MO63144
The crystal structures of etorphine, diprenorphine and oxymorphone were obtained from http://www.opioid.umn.edu/
Clark M, Cramer RDI, van Opdenbosch N (1989) J Comput Chem 10:982–1012
Hom A, Rodgers J (1977) J Pharm Pharmacol 29:257–265
Sagara T, Ozawa S, Kushiyama E, Koike K, Takayanagi I, Kanematsu K (1995) Bioorg Med Chem Lett 5:1505–1508
Nagase H, Hayakawa J, Kawamura K, Kawai K, Takezawa Y, Matsuura H, Tajima C, Endo T (1998) Chem Pharm Bull 46:366–369
Acknowledgement
We appreciated the reviewer’s efforts to improve the quality of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, W., Tang, Y., Xie, Q. et al. 3D–QSAR studies of orvinol analogs as κ-opioid agonists. J Mol Model 12, 877–884 (2006). https://doi.org/10.1007/s00894-005-0084-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-005-0084-9